ESPERITE (ESP) : EUR 1.1 million of new funding provided by L1 Capital to support Esperite’s strategy, commercial activities and development of innovative technologies
Amsterdam, The Netherlands – 10 October 2017
CryoSave continues its European expansion through a partnership with the company Innovatsiyni BioTekhnologiyi, based in Kiev.
Amsterdam, The Netherlands – 9 October 2017
Revenues and results were unexpectedly impacted by pending legal actions.
CEO, Frédéric Amar will convert 1.5 million shares and will subscribe to 1 million new shares to support the business.
Zutphen, the Netherlands – 2 October 2017
ESPERITE N.V. (ESP) delays publication of 2017 Interim Financial Reporting
Zutphen, The Netherlands, 29 September 2017
ESPERITE (ESP): L1 Capital subscribes to the Seventh tranche of investment today
Zutphen, The Netherlands, 31 August 2017
ESPERITE (ESP): L1 Capital confirms its investment in Esperite and announces new funding for up to EUR 0.6 million before August 31, 2017
Zutphen, The Netherlands, 11 August 2017
ESPERITE (ESP): L1 Capital subscribes to the fourth packed tranche of investment today
Zutphen, The Netherlands, 5 July 2017
ESPERITE (ESP): L1 Capital subscribes to the third packed tranche of investment today
Zutphen, The Netherlands, 15 June 2017
L1 Capital confirms its investment in Esperite and announces new funding for up to EUR 1.1 million before July 12, 2017
Zutphen, The Netherlands, 1 June 2017
L1 Capital confirms its investment in Esperite and announces new funding for up to EUR 1.1 million before July 12, 2017
Zutphen, The Netherlands, 31 May 2017
